XBiotech Inc. (XBIT): Total Assets
$150.08M
As of 2025-12-31
$133.65M
As of 2026-06-30
-15.2%
3-year compound annual growth
-15.8%
5-year compound annual growth
+3.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $150.08M | -24.6% | 2026-03-13, Balance as of period end |
| 2024-12-31 | $199.09M | -12.1% | 2026-03-13, Balance as of period end |
| 2023-12-31 | $226.62M | -7.9% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $246.10M | -10.6% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $275.18M | -22.2% | 2023-03-15, Balance as of period end |
| 2020-12-31 | $353.74M | -56.7% | 2022-03-15, Balance as of period end |
| 2019-12-31 | $816.88M | n/m | 2021-03-16, Balance as of period end |
| 2018-12-31 | $44.34M | -29.6% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $62.97M | -6.1% | 2019-03-15, Balance as of period end |
| 2016-12-31 | $67.05M | -38.7% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $109.36M | +75.9% | 2017-03-16, Balance as of period end |
| 2014-12-31 | $62.18M | n/a | 2016-04-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| XBiotech Inc. (XBIT) | 2025-12-31 | $150.08M | -24.6% |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | $150.83M | +114.5% |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | $150.93M | +63.8% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $151.57M | +25.7% |
| Veradermics, Inc (MANE) | 2025-12-31 | $152.62M | +174.8% |
| Larimar Therapeutics, Inc. (LRMR) | 2025-12-31 | $145.84M | -27.2% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $154.69M | +117.6% |
| Precigen, Inc. (PGEN) | 2025-12-31 | $155.50M | +7.0% |
| Boundless Bio, Inc. (BOLD) | 2025-12-31 | $157.06M | -23.9% |
Compare XBIT, WHWK, OVID, CTMX side by side · Screen every company in Pharmaceutical Preparations ↗